(Q38314696)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

Inaki-Carril Mundinano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Irene Marcilla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

María J. Tuñón

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Maria-Rosario Luquin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Maria Hernandez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Carla Dicaudo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Cristina Ordoñez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

20 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

Acta Neuropathologica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

411-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Dopamine neuron systems in the brain: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Cholinergic denervation occurs early in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory dysfunction in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfaction in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Neural correlates of olfactory learning: Critical role of centrifugal neuromodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Administration of MPTP to the common marmoset does not alter cortical cholinergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Direct catecholaminergic-cholinergic interactions in the basal forebrain. II. Substantia nigra-ventral tegmental area projections to cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Disease-specific patterns of locus coeruleus cell loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

The serotonergic system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

The cholinergic system in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Cholinergic structures and neuropathologic alterations in the olfactory bulb of Alzheimer's disease brain samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Co-localization of acetylcholinesterase and choline acetyltransferase in the rat cerebrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Dopamine D1-like receptor-mediated presynaptic inhibition of excitatory transmission onto rat magnocellular basal forebrain neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Anosmia is very common in the Lewy body variant of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

The anterior olfactory nucleus in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Serotonergic modulation of odor input to the mammalian olfactory bulb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Chemical organization of the macaque monkey olfactory bulb: III. Distribution of cholinergic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Cognition and olfaction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

The nucleus basalis of Meynert in neurological disease: a quantitative morphological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Monoaminergic-cholinergic interactions in the primate basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Dopamine-depletion and increased α-synuclein load induce degeneration of cortical cholinergic fibers in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Reduced olfactory bulb and tract volume in early Alzheimer's disease--a MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory impairment predicts brain atrophy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Functional imaging of the cerebral olfactory system in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

Lewy bodies and olfactory dysfunction in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1144-3

10.1007/S00401-013-1144-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 March 2020

1012865236

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23784261%20AND%20SRC:MED&resulttype=core&format=json